Björklund Pharma

Advancing healthcare and wellness

  • Home
  • Company
  • Pipeline
  • Publications
  • Media
  • Contact

Dermatology

Product Candidate

Phenylthiol Hydroxyether: Dermatological Potential

Phenylthiol hydroxyether, characterized by a phenyl ring linked to a thiol (-SH) group, hydroxyl (-OH) groups, and ether (-O-) functionalities, demonstrates dermatological applications. This compound exhibits antimicrobial activity beneficial for acne management, enhances skin barrier integrity, and functions as an efficient vehicle for topical drug delivery in skincare formulations.

The multifaceted properties of phenylthiol hydroxyether underscore its potential as a versatile component in dermatological therapeutics.

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2025 Björklund Pharma AS